抑制GABA(A) 受体α4亚单元可以防止内源性类固醇的戒断特性
1Department of Neurobiology and Anatomy, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania 19129, USA. smiths@auhs.edu
Nature
|May 15, 1998
概括
在老鼠中,孕激素禁用通过降低GABA增强剂3alpha,5alpha-THP的大脑水平来模仿月经前综合征 (PMS) 症状. 这导致的易感性增加和改变GABA (A) 受体表达.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 孕激素在大脑中转化为3alpha,5alpha-THP,增强GABAergic功能.
- 低3alpha,5alpha-THP水平与月经前综合征 (PMS) 症状如焦虑和发作相关.
- 镇静药的戒断会导致类似于PMS的症状.
研究的目的:
- 为了研究产生孕激素戒断引起的变化背后的神经生物学机制.
- 建立一个关于PMS和产后综合征的老鼠模型.
主要方法:
- 在老鼠中开发了一种孕激素戒断模式.
- 测量了发作易感性和对二zepine 的敏感性.
- 分析了GABA(A) 受体子单元的基因转录.
- 评估GABA当前衰变时间.
主要成果:
- 孕激素的戒断增加了发作的易感性和对二zepine的不敏感性.
- 降低的3alpha,5alpha-THP水平与GABA(A) 受体的α4亚单元基因转录减少有关.
- 发作易感性归因于GABA电流衰变时间的减少.
- 阻止α4基因转录可以防止戒断效应.
结论:
- 孕激素戒断会改变GABA (A) 受体子单元的表达,导致PMS症状.
- 对GABAergic抑制的变化在孕激素戒断效应中起着关键作用.
- 鼠标模型有效地模仿了与PMS相关的神经变化.
相关概念视频
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...


